Soma Gold’s El Bagra project joins Colombian coronavirus vaccination program

Soma Gold’s El Bagra project joins Colombian coronavirus vaccination program

Proactive Investors

Published

Soma Gold Corp (CVE:SOMA) (OTCMKTS:SMAGF) (FRA:8PR1) said it is participating in a program initiated by leading Colombian companies in cooperation with the Colombian government to provide coronavirus (COVID-19) vaccinations to employees at its El Bagre mine site, as well as their families.  The program includes acquiring, importing and administering the vaccines at a clinic in El Bagre, in the northeast of Antioquia.  The Colombia-focused precious metals company also announced that during the second quarter ending June 30, 2021, it produced 4,020 gold equivalent ounces and sold 3,799 ounces.  READ: Soma Gold says 1Q revenue topped $9.75M; sets production target date for Nechi Construction at the project’s Fenix and Athena portals accelerated during the quarter, with the Fenix decline expected to reach the vein at Level 2 at the southern end of the deposit by the end of July 2021 and the Athena decline scheduled to reach Level 2 at the northern end of the deposit by September 2021. Full production of 400 tons per day (TPD) from the Cordero mine is expected before the end of the year. The grade at Cordero is expected to be between 6.5 and 8.5 grams per ton gold. "We are pleased with the significant progress made on accessing the Cordero deposit,” Soma's president and CEO Javier Cordova said in a statement. “The 400 TPD we plan to mine at Cordero will supplement the 300-350 TPD we are presently mining at the Mangos Mine. It should allow the company to increase throughput to 650 TPD in the first half of 2022 by re-starting the El Limon mill.” Soma said the average grade will increase as the grade at Cordero is more than 50% higher than the grade at Mangos. This will have a positive effect on gold equivalent production and profitability, the company added. Soma Gold also owns an exploration and development property near Tucuma, Brazil. Contact the author at stephen.gunnion@proactiveinvestors.com

Full Article